Krishna Institute of Medical Sciences Ltd Q2 FY26 Results
KIMSQ2 FY26 ResultsAnnounced 7 Nov 2025, 02:42 pm| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 960.70 | 10.2% | 23.6% |
| Total Income | 964.90 | 9.8% | 23.3% |
| Expenditure | 867.80 | 13.4% | 40.0% |
| PBT | 96.80 | 14.9% | 40.3% |
| Net Profit | 72.00 | 15.3% | 40.4% |
| OPM | 21.20% | 0.90pp | 8.81pp |
| NPM | 7.46% | 2.21pp | 7.97pp |
| EPS | 1.67 | 14.8% | 37.7% |
KIMS Hospitals Reports Q2 FY26 Financial Results with 23.3% YoY Growth
07 Nov 2025 · 7 Nov 2025, 05:50 pm
Summary
Krishna Institute of Medical Sciences Ltd (KIMS Hospitals) reported their financial results for the second quarter and half-year ended 30th September 2025. The company saw a total revenue of INR 965 Cr, a growth of 23.3% on YoY and 9.8% on QoQ basis. The EBITDA was INR 208 Cr, a growth of 6.7% on YoY and 4.3% on QoQ basis. The EBITDA margin was at 21.6% vs. 28.5% in Q2 FY25 and 22.7% in Q1 FY26. The PAT was INR 72 Cr in Q2 FY26 against INR 121 Cr and INR 85 Cr in Q2 FY25 and Q1 FY26 respectively. The Consolidated EPS for Q2 FY26 was INR 1.67, a degrowth of 37.7% on YoY basis and 14.7% QOQ respectively.
Key Highlights
- 1
Total Revenue of INR 965 Cr, a growth of 23.3% on YoY and 9.8% on QoQ basis.
- 2
EBITDA of INR 208 Cr, a growth of 6.7% on YoY and a growth of 4.3% on QoQ basis.
- 3
EBITDA margin at 21.6% vs. 28.5% in Q2 FY25 and 22.7% in Q1 FY26.
- 4
=PAT at INR 72 Cr in Q2 FY26 against INR 121 Cr and INR 85 Cr in Q2 FY25 and Q1 FY26 respectively.
- 5
Consolidated EPS for Q2 FY26 of INR 1.67, a degrowth of 37.7% on YoY basis and 14.7% QOQ respectively.
- 6
Cash and Cash Equivalents at INR 120 Cr as on 30th September 2025.
Management Comments
Not provided in the document.
Not provided in the document.
Informational and educational content only. Not investment advice.